Table 6.
Complement and s-endoglin deposition in preeclampsia (PE) vs. control.
| dg | C3b/iC3b |
C1q |
C4bp |
C4 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Control |
Control |
Control |
Control |
||||||||||
| t | p | df | t | p | df | t | p | df | t | p | df | ||
| Sum | PE | −1.417 | −0.172 | 20 | −1.695 | 0.106 | 20 | −0.775 | 0.448 | 19 | 0.848 | 0.407 | 19 |
| Mean | PE | −1.366 | 0.187 | 20 | −1.493 | 0.151 | 20 | −0.602 | 0.554 | 19 | −0.664 | 0.515 | 19 |
| dg |
FH |
C3d |
C9 |
s-Endoglin |
|||||||||
|
Control |
Control |
Control |
Control |
||||||||||
| t | p | df | t | p | df | t | p | df | t | p | df | ||
| Sum | PE | 0.458 | 0.652 | 20 | 0.045 | 0.964 | 20 | −0.411 | 0.685 | 20 | 2.008 | 0.059 | 19 |
| Mean | PE | 0.407 | 0.689 | 20 | −0.398a | 0.695 | 18.961 | −0.330 | 0.745 | 20 | 2.463 | 0.023 | 19 |
Pooled PE and controls compared using mean fluorescence intensity and sum of intensity as measurements. Only soluble endoglin is significantly (mean) or borderline (sum) significantly different across the groups.
aEqual variances not assumed.
Bold significant to the 0.05 level.
Italics borderline significant.
df, degrees of freedom.
dg, diagnosis.